Drug intelligence / Profile preview

flavone

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Flavone is a naturally occurring compound and the core structure of a class of polyphenolic phytochemicals known as flavones, which are widely distributed in plants. Flavones are characterized by a phenyl ring attached to chromone at the 2-position and are considered major plant secondary metabolites[5]. Flavone itself, as well as its derivatives (such as apigenin and luteolin), have been studied for their diverse biological activities, including anti-inflammatory, antioxidant, anticancer, antibacterial, and neuroprotective effects[5][4][8]. Mechanistically, flavones act through multiple pathways: - Inhibition of oxidative stress by scavenging free radicals and chelating metal ions[8][4]. - Modulation of inflammatory responses via inhibition of enzymes such as cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX)[5]. - Inhibition of aromatase activity (aromatase inhibitor), androgen receptor inhibition, gamma-aminobutyric acid receptor subunit alpha-1 inhibition[2]. Despite promising preclinical data for various indications such as cancer prevention/treatment and vascular health support, clinical development has been limited due to poor bioavailability. Flavone is not an approved pharmaceutical drug but serves primarily as a research chemical or dietary supplement component[2][1].

Other names
2-phenylchromen-4-one
02

Targets

GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)AR (Adrenergic receptors)CYP19A1 (Aromatase)

Beyond the preview

Go deeper on flavone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flavone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call